Summary
Plasma luteinizing hormone (LH) levels were significantly lower in 10 postmenopausal women with Parkinson's disease (PD) compared to agematched controls. The remaining hypophyseal hormones and gonadal steroids were similar in PD patients and in controls, suggesting a selective alteration of hypothalamic dopaminergic mechanisms which regulate LH secretion.
This is a preview of subscription content, log in via an institution to check access.
References
Barraclough DA, Wise PM (1982) The role of cathecolamines in the regulation of pituitary luteinizing hormone and follicle-stimulating hormone secretion. Endocr Rev 3: 91–119
Brown E, Brown GH, Kofman O, Quarrington B (1978) Sexual function and affect in parkinsonian men treated with L-Dopa. Am J Psychiatry 135: 1552–1555
Conte-Devolx B, Pfister B, Rey M, Conte-Devolx J, (1987) La function endocrine ante-hypophysaire dans la maladie de Parkinson. Presse Med 12: 566–568
Den Hartog WA, Bethlem J (1960) The distribution of Lewy bodies in the central and autonomic nervous system in idiopathic paralisis agitans. J Neurol Neurosurg Psychiatry 23: 283–290
Fahn S, Elton RL, Agid Y, Barbeau A, Calne DB, Duvoisin RC, Hoehn MM, Jankovic J, Klawans HL, Lang AE, Lataste X, Liebermann AN, Marsden CD, Markham CH, Mayeux R, Rinne UK, Stern GM, Teychenne P, Yahr MD (1987) Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in Parkinson's disease, vol 2. Mcmillan Healthcare Information, New York, pp 153–163
Fioretti P, Cagnacci A, Paoletti AM, Gambacciani M, Soldani R, Mauro GA, Melis GB (1989) Effects of the antidopaminergic drug veralipride on LH and PRL secretion in postmenopausal women. J Endocrinol Invest 12: 295–301
Forno LS, Norville RL (1981) Synaptic morphology in the human locus coeruleus. Acta Neuropathol 53: 524–531
Gambacciani M, Melis GB, Paoletti AM, Cagnacci A, Mais V, Petacchi FD, Fioretti P (1987) Pulsatile luteinizing hormone relase in postmenopausal women: effect of chronic bromocriptine administration. J Clin Endocrinol Metab 65: 465–467
Gross KM, Matsumoto AM, Bremner WJ (1987) Differential control of luteinizing hormone and follicle-stimulating hormone secretion by luteinizing hormone-releasing hormone pulse frequency in man. J Clin Endocrinol Metab 64: 675–680
Hall JE, Brodie TD, Badger TM, Rivier J, Vale W, Conn PM, Shoenfeld D, Crowley WF (1988) Evidence of differential control of FSH and LH secretion by gonadotropinreleasing hormone (Gn RH) from the use of a Gn RH antagonist J Clin Endocrinol Metab 7: 524–531
Hornykiewicz C, Kish SJ (1986) Biochemical pathophysiology of Parkinson's disease. Adv Neurol 45: 19–34
Hyyppa MT, Langvik VA, Rinne UK (1978) Plasma pituitary hormones, in patients with Parkinson's disease treated with bromocriptine. J Neural Transm 42: 151–157
Javoy-Agid F, Ruberg M, Pique L, Bertagna X, Taquet H, Studler JM, Cesselin F, Epelbaum J, Agid Y (1984) Biochemistry of hypothalamus in Parkinson's disease. Neurology 34: 672–675
Kirkpatrick B, Tamminga CA (1988) The endocrinology of extrapyramidal disorders. Neurol Clin 6: 159–172
Lachelin GCL, Leblanc H, Yen SSC (1977) The inhibitory effect of dopamine-agonists on LH release in women. J Clin Endocrinol Metab 44: 728–732
Langston JW, Forno LS (1978) The hypothalamus in, Parkinson's disease. Ann Neurol 3: 129–133
Leblanc H, Lachelin GCL, Abu-Fadil S, Yen SSC (1976) Effect of dopamine infusion on pituitary hormone secretion in humans. J Clin Endocrinol Metab 43: 668–674
Ling N, Ying SY, Ueno N, Shimasaki S, Esh F, Hotta M, Guillemin R (1986) Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibin. Nature 321: 779–782
Lundberg PO (1972) Blood levels of FSH, LH, TSH and GH in parkinsonian patients before and during L-Dopa treatment. Acta Neurol Scand 48: 427–432
Melis GB, Paoletti AM Mais V, Gambacciani M, Guarnieri G, Strigini F, Fruzzetti F, Fioretti P (1981) Inhibitory effect of the dopamine agonist bromocriptine on the postcastration gonadatropin rise in women. J Clin Endocrinol Metab 53: 530–535
Martin JB, Reichlin S (1987) Neuropharmacology of anterior pituitary, regulation. In: Martin JB, Reichlin S (eds) Clinical neuroendocrinology. FA Davis, Philadelphia, p 45
Nappi G, Petraglia F, Martignoni E, Facchinetti F, Bono G, Genazzani AR (1985) β-Endorphin cerebrospinal fluid decrease in untreated parkinsonian patients. Neurology 35: 1371–1374
Rasmussen DD, Liu JH, Wolf PK, Jen SSC (1986) Gonadotropin-releasing hormone neurosecretion in the human hypothalamus. In vitro regulation by dopamine. J Clin Endocrinol Metab 62: 479–483
Reid RL, Quigley ME, Yen SSC (1983) The disappearacne of opioidergic regulation of gonadotropin secretion in postmenopausal women. J Clin Endocrinol Metab 57: 1107–1110
Rinne UK (1979) Neuroendocrine and extrapyramidal dopamine neurons in Parkinson's disease. In: Muller EE, Agnoli A (eds) Neuroendocrine correlates in neurology and psychiatry. Elsevier, Amsterdam, pp 119–125
Rivier C, Rivier J, Vale W (1986) Inhibin-mediated feedback control of follicle-stimulating hormone secretion in the female rate. Science 234: 205–208
Vale W, Rivier J, Vaughan J, McClintock R, Corrigan A, Woo W, Karr D, Spiess J (1986) Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 321: 776–779
Veldhuis JD, Evans WS, Rogol AD, Thorner MO, Drake CR, Merriam GR, Johnson ML (1984) Intensified rates of venous sampling unmask the presence of spontaneous high frequency pulsations of luteinizing hormone in man. J Clin Endocrinol Metab 59: 96–102
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bonuccelli, U., Piccini, P., Napolitano, A. et al. Reduced luteinizing hormone secretion in women with Parkinson's disease. J Neural Transm Gen Sect 2, 225–231 (1990). https://doi.org/10.1007/BF02257653
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02257653